IDH2 and malignant glioma: Unlike human TP53-mutant IDH-WT proneural GBMs that frequently exhibited genetic alterations of PDGFRα (Supplementary Fig. 1m)1, no evidence of genetic Pdgfrα abnormality was found in malignant gliomas and GBMs from all three p53CKO models.